ConCallIQ
Go Pro
SBILIFE Healthcare 20 Jul 2023

Sbilife Ltd — Q1 FY24

SBI Life reported a decent Q1 FY24 on a high base, with individual new business premium growing 18% YoY to INR 40.6 billion and PAT up 45% YoY to INR 3.8 billion.

neutral medium
Compare with...
Revenue
EBITDA
PAT ₹380 Cr +45%
EBITDA Margin
Duration
Read Time 1 min read

Financial stats pending filing verification

Risk Intelligence

Material risks this quarter

Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.

Risks

R

Potential margin pressure from increased distributor commissions

Regulatory changes (EOM guidelines) may lead to higher commission payouts, especially to SBI, potentially compressing VNB margins.

medium · analyst_question
R

Persistency decline in near-term cohorts

13-month and 25-month persistency dipped slightly, which could impact future renewal premiums and embedded value if not reversed.

medium · data_observation
R

High base effect may constrain growth in coming quarters

Last year's exceptional Q1 growth (86% in individual rated) creates a high base; sustaining 20%+ growth for the full year requires strong performance in subsequent quarters.

low · management_commentary